Real-world experience of immune checkpoint inhibitors in MSI-H/dMMR metastatic colorectal cancer in a tertiary cancer center in Saudi Arabia

被引：0
|
作者：
Ajina, R. [1 ]
Alhareeri, A. [1 ]
Philip, W. [1 ]
Alsekait, N. [2 ]
Alarifi, N. [2 ]
Alismail, H. [1 ]
Alshieban, S. [3 ]
Almuzzaini, B. [4 ]
Alshammari, K. [5 ]
机构：
[1] King Saud bin Abdulaziz Univ Hlth Sci, KAIMRC, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[2] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia
[3] King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, KAIMRC, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[4] KSAU HS, King Abdullah Int Med Res Ctr, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[5] Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.344
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-288
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [21] Real-world treatment patterns and clinical outcomes for chemotherapy-based regimens in first-line MSI-H/dMMR metastatic colorectal cancer
    Amonkar, Mayur M.
    Chase, Monica
    Myer, Nicole M.
    Wang, Tongtong
    Turzhitsky, Vladimir
    Spira, Alexander
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 36
  • [22] Natural history and patterns of progression for dMMR/MSI-H colorectal cancer treated with immune checkpoint blockade: A single center retrospective analysis.
    Higbie, Victoria
    Shah, Preksha
    Bent, Alisha Heather
    Dasari, Arvind
    Huey, Ryan W.
    Johnson, Benny
    Kee, Bryan K.
    Kopetz, Scott
    Lee, Michael Sangmin
    Ludford, Kaysia
    Morelli, Maria Pia
    Morris, Van K.
    Parseghian, Christine Megerdichian
    Raghav, Kanwal Pratap Singh
    Shen, John Paul Y. C.
    Willis, Jason
    Wolff, Robert A.
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 145 - 145
  • [23] The Role of CTLA-4 Inhibition in Immunotherapy for MSI-H/ dMMR Metastatic Colorectal Cancer
    Wu, Christina S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2025, 23 (01) : 18 - 20
  • [24] Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
    Oliveira, Andre F.
    Bretes, Luis
    Furtado, Irene
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [25] Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
    Mulet-Margalef, Nuria
    Linares, Jenniffer
    Badia-Ramentol, Jordi
    Jimeno, Mireya
    Monte, Carolina Sanz
    Mozo, Jose Luis Manzano
    Calon, Alexandre
    CANCERS, 2023, 15 (04)
  • [26] NIVOLUMAB HAS ANTITUMOR ACTIVITY IN DMMR/MSI-H COLORECTAL CANCER
    CANCER DISCOVERY, 2017, 7 (09) : 930 - 930
  • [27] Analysis of HLA gene expression in patients with dMMR/MSI-H colorectal carcinoma resistant to immune checkpoint inhibitors.
    Lenz, Heinz-Josef
    Nicolaides, Theodore
    Elliott, Andrew
    Goldberg, Richard M.
    Marshall, John
    Lou, Emil
    Shields, Anthony Frank
    Sohal, Davendra
    Weinberg, Benjamin Adam
    Spetzler, David
    Abraham, Jim
    Xiu, Joanne
    Korn, Wolfgang Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 202 - 202
  • [28] Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSI-H Locally Advanced Colorectal Cancer: A Single-Center Real-World Study
    Zhang, Xuan
    Yang, Renfang
    Wu, Tao
    Cai, Xinyi
    Li, Guoyu
    Yu, Kun
    Li, Yong
    Ding, Rong
    Dong, Chao
    Li, Jinsha
    Hu, Ruixi
    Feng, Qing
    Li, Yunfeng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors
    Ziranu, Pina
    Pretta, Andrea
    Pozzari, Marta
    Maccioni, Antonio
    Badiali, Manuela
    Fanni, Daniela
    Lai, Eleonora
    Donisi, Clelia
    Persano, Mara
    Gerosa, Clara
    Puzzoni, Marco
    Bardanzellu, Fabio
    Ambu, Rossano
    Pusceddu, Valeria
    Dubois, Marco
    Cerrone, Giulia
    Migliari, Marco
    Murgia, Sara
    Spanu, Dario
    Pretta, Gianluca
    Aimola, Valentina
    Balconi, Francesca
    Murru, Stefania
    Faa, Gavino
    Scartozzi, Mario
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [30] CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors
    Pina Ziranu
    Andrea Pretta
    Marta Pozzari
    Antonio Maccioni
    Manuela Badiali
    Daniela Fanni
    Eleonora Lai
    Clelia Donisi
    Mara Persano
    Clara Gerosa
    Marco Puzzoni
    Fabio Bardanzellu
    Rossano Ambu
    Valeria Pusceddu
    Marco Dubois
    Giulia Cerrone
    Marco Migliari
    Sara Murgia
    Dario Spanu
    Gianluca Pretta
    Valentina Aimola
    Francesca Balconi
    Stefania Murru
    Gavino Faa
    Mario Scartozzi
    Scientific Reports, 13
12345